Isoniazid for the tuberculin reactor: take it or leave it.
暂无分享,去创建一个
J Tsevat | J B Wong | S G Pauker | J. Wong | J. Tsevat | W. C. Taylor | W C Taylor | S. Pauker
[1] S. Pauker,et al. The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] G. Comstock. Prevention of tuberculosis among tuberculin reactors: maximizing benefits, minimizing risks. , 1986, JAMA.
[3] M. Aronson,et al. Should young adults with a positive tuberculin test take isoniazid? , 1981, Annals of internal medicine.
[4] D. Snider,et al. Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. , 1986, JAMA.
[5] M. Weinstein,et al. Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.
[6] C. Schechter,et al. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. , 1986, JAMA.
[7] D. Snider,et al. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. , 1978, The American review of respiratory disease.
[8] G. Comstock,et al. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. , 2015, The American review of respiratory disease.
[9] D. Snider,et al. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. , 2015, The American review of respiratory disease.
[10] J. Koplan,et al. Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. , 1980, JAMA.
[11] Ferebee Sh. Controlled chemoprophylaxis trials in tuberculosis. A general review. , 1970 .
[12] I. D. Bobrowitz. Active tuberculosis undiagnosed until autopsy. , 1982, The American journal of medicine.
[13] W. A. Lott,et al. Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds. , 1952, American review of tuberculosis.
[14] J. Noble. Isoniazid prophylaxis re-examined. , 1971, The New England journal of medicine.
[15] K. Ishak,et al. Isoniazid-associated hepatitis in 114 patients. , 1975, Gastroenterology.
[16] James K. Cooper. Decision Analysis for Tuberculosis Preventive Treatment in Nursing Homes , 1986, Journal of the American Geriatrics Society.
[17] G. Comstock,et al. Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. , 1976, Public health reports.
[18] B. McNeil,et al. Fallacy of the five-year survival in lung cancer. , 1978, The New England journal of medicine.
[19] B. A. Bush,et al. Tuberculosis. Cause of death in antibiotic era. , 1985, Chest.
[20] T. Moulding. Chemoprophylaxis of tuberculosis: when is the benefit worth the risk and cost? , 1971, Annals of internal medicine.
[21] E. Podack,et al. Interleukin 2 therapy for disseminated cancer. , 1987, JAMA.
[22] Iuat. Efficacy of various duration of isoniazid preventive therapy for tuberculosis : five years follow-up in the IUAT trial , 1982 .
[23] O. Horwitz,et al. Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. , 1969, Bulletin of the World Health Organization.
[24] B. McNeil,et al. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. , 1981, The New England journal of medicine.
[25] W. Stead. Tuberculosis among elderly persons: an outbreak in a nursing home. , 1981, Annals of internal medicine.